论文信息 - Megestrol acetate (MGA) plus alpha 2A interferon (IFN) as second line therapy in patients (pts) with advanced breast cancer (a.b.c.): Preliminary results of a multicentric phase II trial - 字舞流文

Megestrol acetate (MGA) plus alpha 2A interferon (IFN) as second line therapy in patients (pts) with advanced breast cancer (a.b.c.): Preliminary results of a multicentric phase II trial

G. Failla | M. Mesiti | F. Boccardo | R. Cellerino | F. Brema | D. Amoroso | A. Farris | G. Mustacchi | L. Miglietta | P. Gallotti | P. Spadaro | M. Balestrero | U. Foico | S. Iacobell